Wave Life Sciences Ltd. Y95308105 SG9999014716 08/05/2025 To approve, by a non-binding advisory vote, the compensation of our named executive officers as disclosed in the proxy statement SECTION 14A SAY-ON-PAY VOTES 40000 0 FOR 40000 FOR 1 Wave Life Sciences Ltd. Y95308105 SG9999014716 08/05/2025 To approve, on a non-binding, advisory basis only, the frequency of holding future shareholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 40000 0 ONE YEAR 40000 FOR 1 Verona Pharma Plc 925050106 US9250501064 09/24/2025 To approve, on an advisory, non-binding basis, the compensation that may be paid or become payable to the Company's named executive officers in connection with the Transaction, as disclosed in the table entitled "Potential Payments to Named Executive Officers" beginning on page 70 of the proxy statement, including the associated narrative discussion, and the agreements or understandings pursuant to which such compensation may be paid or become payable. SECTION 14A SAY-ON-PAY VOTES 55000 0 FOR 55000 FOR 1 Rezolute, Inc. 76200L309 US76200L3096 11/19/2025 To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers as disclosed in the Executive Compensation section of the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 275000 0 AGAINST 275000 AGAINST 1 Johnson & Johnson 478160104 US4781601046 04/23/2026 Advisory Vote to Approve Named Executive Officer Compensation SECTION 14A SAY-ON-PAY VOTES 6000 0 FOR 6000 FOR 1 Biohaven Ltd. G1110E107 VGG1110E1079 04/28/2026 A non-binding advisory vote on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 60720 0 FOR 60720 FOR 1 Bristol-Myers Squibb Company 110122108 US1101221083 05/05/2026 Advisory Vote to Approve the Compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES 16000 0 FOR 16000 FOR 1 LPL Financial Holdings Inc. 50212V100 US50212V1008 05/14/2026 Approve, in an advisory vote, the compensation paid to the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 16500 0 FOR 16500 FOR 1 Mereo BioPharma Group Plc 589492107 US5894921072 05/14/2026 That the compensation of the Company's named executive officers be approved, on an advisory (non-binding) basis. SECTION 14A SAY-ON-PAY VOTES 300337 0 FOR 300337 FOR 1 Ultragenyx Pharmaceutical Inc. 90400D108 US90400D1081 05/14/2026 Advisory (non-binding) vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 21069 0 FOR 21069 FOR 1 AtriCure, Inc. 04963C209 US04963C2098 05/18/2026 Advisory vote on the compensation of our named executive officers as disclosed in the proxy statement for the 2026 Annual Meeting. SECTION 14A SAY-ON-PAY VOTES 51400 0 FOR 51400 FOR 1 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/19/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 140633 0 FOR 140633 FOR 1 Travere Therapeutics, Inc. 89422G107 US89422G1076 05/19/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 140633 0 ONE YEAR 140633 FOR 1 Alkermes plc G01767105 IE00B56GVS15 05/20/2026 To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 120000 0 FOR 120000 FOR 1 Vera Therapeutics, Inc. 92337R101 US92337R1014 05/21/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 26000 0 FOR 26000 FOR 1 Verastem, Inc. 92337C203 US92337C2035 05/21/2026 To approve an advisory vote on the compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES 94000 0 FOR 94000 FOR 1 Cytokinetics, Incorporated 23282W605 US23282W6057 05/27/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 23644 0 FOR 23644 FOR 1 ADMA Biologics, Inc. 000899104 US0008991046 06/02/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 60200 0 FOR 60200 FOR 1 Viridian Therapeutics, Inc. 92790C104 US92790C1045 06/02/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 181000 0 FOR 181000 FOR 1 Viridian Therapeutics, Inc. 92790C104 US92790C1045 06/02/2026 To approve, on an advisory basis, the frequency of holding an advisory vote on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 181000 0 ONE YEAR 181000 FOR 1 Kura Oncology, Inc. 50127T109 US50127T1097 06/04/2026 Approval, on an advisory basis, of the compensation of our named executive officers ("Say-on-Pay"), as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 52767 0 FOR 52767 FOR 1 Kura Oncology, Inc. 50127T109 US50127T1097 06/04/2026 Indication, on an advisory basis, of the preferred frequency of holding future Say-on-Pay votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES 52767 0 ONE YEAR 52767 FOR 1 Xeris Biopharma Holdings, Inc. 98422E103 US98422E1038 06/04/2026 To approve, on a non-binding advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 1060000 0 FOR 1060000 FOR 1 Apollo Global Management, Inc. 03769M106 US03769M1062 06/08/2026 An advisory vote to approve the compensation of AGM's named executive officers (Say on Pay); SECTION 14A SAY-ON-PAY VOTES 225000 0 AGAINST 225000 AGAINST 1 Apollo Global Management, Inc. 03769M106 US03769M1062 06/08/2026 An advisory vote on the frequency of future advisory votes to approve the compensation of AGM's named executive officers (Say on Frequency); and SECTION 14A SAY-ON-PAY VOTES 225000 0 ONE YEAR 225000 AGAINST 1 Biogen Inc. 09062X103 US09062X1037 06/09/2026 Say on Pay - To hold an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES 4000 0 FOR 4000 FOR 1 Cogent Biosciences, Inc. 19240Q201 US19240Q2012 06/09/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 104000 0 FOR 104000 FOR 1 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/10/2026 To approve, by non-binding advisory vote, the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES 1600000 0 AGAINST 1600000 AGAINST 1 Iovance Biotherapeutics, Inc. 462260100 US4622601007 06/10/2026 To approve, by non-binding advisory vote, the frequency of our future votes on the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES 1600000 0 ONE YEAR 1600000 FOR 1 Solid Biosciences Inc. 83422E204 US83422E2046 06/10/2026 The approval of an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES 47143 0 AGAINST 47143 AGAINST 1 Syndax Pharmaceuticals, Inc. 87164F105 US87164F1057 06/10/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2026 proxy statement. SECTION 14A SAY-ON-PAY VOTES 422000 0 FOR 422000 FOR 1 Arcus Biosciences, Inc. 03969F109 US03969F1093 06/11/2026 To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 81241 0 FOR 81241 FOR 1 Evolus, Inc. 30052C107 US30052C1071 06/11/2026 Approval of, on an advisory basis, the compensation of Evolus' named executive officers. SECTION 14A SAY-ON-PAY VOTES 99338 0 FOR 99338 FOR 1 TG Therapeutics, Inc. 88322Q108 US88322Q1085 06/11/2026 An advisory vote to approve the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 96001 0 AGAINST 96001 AGAINST 1 Ardelyx, Inc. 039697107 US0396971071 06/16/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"); SECTION 14A SAY-ON-PAY VOTES 207000 0 FOR 207000 FOR 1 Ardelyx, Inc. 039697107 US0396971071 06/16/2026 To approve, on a non-binding, advisory basis, whether a Say-on-Pay vote should occur every one (1) year, every two (2) years or every three (3) years; SECTION 14A SAY-ON-PAY VOTES 207000 0 ONE YEAR 207000 FOR 1 Cullinan Therapeutics, Inc. 230031106 US2300311063 06/16/2026 Proposal to vote, on an advisory basis, to approve our named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES 24200 0 FOR 24200 FOR 1 DocGo Inc. 256086109 US2560861096 06/16/2026 To approve on a non-binding, advisory basis the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 2670850 0 FOR 2670850 FOR 1 Madrigal Pharmaceuticals, Inc. 558868105 US5588681057 06/17/2026 Advisory vote to approve executive compensation SECTION 14A SAY-ON-PAY VOTES 2000 0 FOR 2000 FOR 1 Protagonist Therapeutics, Inc. 74366E102 US74366E1029 06/17/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 63000 0 FOR 63000 FOR 1 Agios Pharmaceuticals, Inc. 00847X104 US00847X1046 06/18/2026 To vote, on an advisory basis, to approve the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES 93058 0 FOR 93058 FOR 1 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/22/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES 90000 0 FOR 90000 FOR 1 BridgeBio Pharma, Inc. 10806X102 US10806X1028 06/22/2026 To conduct a non-binding advisory vote on the frequency of future non-binding advisory votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 90000 0 ONE YEAR 90000 FOR 1 Orchestra Biomed Holdings, Inc. 68572M106 US68572M1062 06/23/2026 Adoption of an advisory (non-binding) resolution approving the compensation of our "named executive officers". SECTION 14A SAY-ON-PAY VOTES 253651 0 AGAINST 253651 AGAINST 1 Orchestra Biomed Holdings, Inc. 68572M106 US68572M1062 06/23/2026 Advisory (non-binding) vote on the frequency of future advisory (non-binding) votes on the compensation of our "named executive officers". SECTION 14A SAY-ON-PAY VOTES 253651 0 ONE YEAR 253651 FOR 1 Microsoft 594918104 US5949181045 12/05/2025 Approve, on a nonbinding advisory basis, the compensation paid to our named executive officers ("say-on-pay vote") SECTION 14A SAY-ON-PAY VOTES 1600 0 FOR 0 FOR Pfizer InC 717081103 US7170811035 04/22/2026 2026 advisory approval of executive compensation SECTION 14A SAY-ON-PAY VOTES 32337 0 FOR 0 FOR DuPont de Nemours Inc 26614N201 US26614N2018 05/21/2026 Advisory resolution to approve executive compensation SECTION 14A SAY-ON-PAY VOTES 32767 0 FOR 0 FOR Brightstar Lottery PLC GB00BVG7F061 05/12/2026 That the directors' renumeration report (excluding the part containing the directors' renumeration policy) for the financial year ended Dec 31 2025 set out in the Annual Report and Accounts be approved SECTION 14A SAY-ON-PAY VOTES 2500 0 FOR 0 FOR Kimberly-Clark Corp 494368103 US4943681035 05/14/2026 Approve the compensation for our named executive officers in an advisory vote SECTION 14A SAY-ON-PAY VOTES 2400 0 FOR 0 FOR Rhyman Hospitality Properties Inc 78377T107 US78377T1079 05/07/2026 To approve, on an advisory basis, our executive compensation SECTION 14A SAY-ON-PAY VOTES 2400 0 FOR 0 FOR Amazon.com Inc 023135106 US0231351067 05/20/2026 Advisory vote to approve executive compensation SECTION 14A SAY-ON-PAY VOTES 300 0 FOR 0 FOR Canadian Natural Resources 136385101 CA1363851017 05/07/2026 On an advisory basis accepting the Corporation's approach to executive compensation as described in the offering cicular SECTION 14A SAY-ON-PAY VOTES 16800 0 FOR 0 FOR JP Morgan Chase 46625H100 US46625H1005 05/19/2026 Advisory resolution to approve executive compensation SECTION 14A SAY-ON-PAY VOTES 18829 0 FOR 0 FOR Unitedhealth Group Inc 91324P102 US91324P1021 04/02/2026 Advisory approval of the Company's executive compensation SECTION 14A SAY-ON-PAY VOTES 57 0 FOR 0 FOR United Rental Inc 911363109 US9113631090 05/07/2026 Advsory approval of executive compensation SECTION 14A SAY-ON-PAY VOTES 78 0 FOR 0 FOR Eastern Bancshares Inc 27627N105 US27627N1054 05/18/2026 to hold an advisory vote on executive compensation; SECTION 14A SAY-ON-PAY VOTES 5000 0 FOR 0 FOR Kyndryl Holdings Inc 50155Q100 US50155Q1004 07/30/2026 Approval, in an advisory non-binding vote, of the compensation of named executive officers SECTION 14A SAY-ON-PAY VOTES 428 0 FOR 0 FOR Occidental Petroleum Corp 674599105 US6745991058 05/01/2026 Advisory vote to approve named executive officer compensation SECTION 14A SAY-ON-PAY VOTES 469 0 FOR 0 FOR Starwood Property Trust Inc 85571B105 US85571B1052 04/23/2026 The approval, on an advisory basis, of the Company's executive compensation SECTION 14A SAY-ON-PAY VOTES 400 0 FOR 0 FOR Corteva Inc 22052L104 US22052L1044 04/28/2026 advisory resolution to aprove executive compensation of the company's named executive officers SECTION 14A SAY-ON-PAY VOTES 1206 0 FOR 0 FOR Dow Inc 260557103 US2605571031 04/09/2026 advisory resolution to approve executive compensation SECTION 14A SAY-ON-PAY VOTES 1206 0 FOR 0 FOR GE Healthcare Technology 36266G107 US36266G1076 05/07/2026 Approval of named executive officer's compensation in an advisory vote SECTION 14A SAY-ON-PAY VOTES 50 0 FOR 0 FOR Mondelez International Inc 609207105 US6092071058 05/20/2026 advisory vote to approve executive compensation for our listed officers SECTION 14A SAY-ON-PAY VOTES 3000 0 FOR 0 FOR Apple Inc 037833100 US0378331005 02/24/2026 advisory vote to approve Executive Compensation SECTION 14A SAY-ON-PAY VOTES 2100 0 FOR 0 FOR Heineken NV 423012301 US4230123014 08/05/2026 Composition Executive Board SECTION 14A SAY-ON-PAY VOTES 400 0 FOR 0 FOR Johnson & Johnson 478160104 US4781601046 04/23/2026 Advisory vote to approve named Executive Compensation SECTION 14A SAY-ON-PAY VOTES 922 0 FOR 0 FOR Wabtec Corp 929740108 US9297401088 05/12/2026 approve an adivisory (non-binding) resolution to approve 2025 named executive compensation SECTION 14A SAY-ON-PAY VOTES 6 0 FOR 0 FOR Alphabet Inc A 02079K305 US02079K3059 06/05/2026 advisory vote to approve compensation awarded to named executive officers SECTION 14A SAY-ON-PAY VOTES 520 0 FOR 0 FOR Broadcom Inc 11135F101 US11135F1012 04/20/2026 advisory vote to approve named executive compensation SECTION 14A SAY-ON-PAY VOTES 710 0 FOR 0 FOR Danaher Corp 235851102 US2358511028 05/05/2026 We are asking our shareholders to cast a non-binding, advisory vote on the compensation of the executive officers named in the 2025 Summary Compensation Table (the “named executive officers” or “NEOs”) on page 52. In evaluating this year’s “say on pay” proposal, we recommend that you review our Compensation Discussion and Analysis, which explains how and why the Compensation Committee of our Board arrived at its executive compensation actions and decisions for 2025 SECTION 14A SAY-ON-PAY VOTES 180 0 FOR 0 FOR Nvidia Corp 67066G104 US67066G1040 06/24/2026 Advisory Approval of our executive compensation SECTION 14A SAY-ON-PAY VOTES 1280 0 FOR 0 FOR Quanta Services Inc 74762e102 US74762E1029 05/21/2026 Approve by non-binding advosory vote, of the compensation of Quanta's named executive officers for fiscal year 2025 SECTION 14A SAY-ON-PAY VOTES 176 0 FOR 0 FOR Salesforce Inc. 79466L302 US79466L3024 05/26/2026 to approve on an advisory basis the fiscal 2026 compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES 77 0 FOR 0 FOR